Name: Latest research reports of Divi's Laboratories Ltd. authored by Motilal Oswal and published by - Trendlyne research reports.
Item: Divi's Laboratories Ltd.
Rating: 3
Author: Motilal Oswal

Divi's Laboratories Ltd.

NSE: DIVISLAB | BSE: 532488 | ISIN: INE361B01024 | Industry: Pharmaceuticals
| Expensive Performer

6373.0000 -89.50 (-1.38%)

NSE Nov 21, 2025 15:31 PM

28.62% Gain from 52W Low

Volume: 130.8K

Divi's Laboratories Ltd.

12 Aug 2019

6373.00

-1.38%

Adverse macro situation for raw materials impacts profitability

Neutral: Divi's Laboratories Ltd.

Motilal Oswal

Adverse macro situation for raw materials impacts profitability Motilal Oswal values your support in the Asiamoney Brokers Poll 2019 for...

Divi's Laboratories .. has an average target of 6432.50 from 6 brokers.